Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04290533
Other study ID # 17612
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 4, 2019
Est. completion date January 15, 2020

Study information

Verified date May 2021
Source Monash University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Psychological disorders characterized by impulsivity often show alterations in dorsal anterior cingulate cortex (dACC) activity. Recent research has therefore focused on non-invasive neurostimulation therapies for the modulation of functional activity in the dACC. To date there has only been one proof-of-concept study providing evidence for modulating dACC activity with non-invasive electrical neurostimulation (e.g. transcranial electrical stimulation). Since transcranial Direct Current Stimulation (tDCS) is relatively safe, tolerable, and mobile as compared to other neurostimulation techniques, it is worthwhile looking further into the effects of tDCS on functional dACC activity. The aim of the present research is to explore whether HD-tDCS can induce changes in the dACC in individuals with high trait impulsivity (N=20) in a double-blind cross-over study. Functional changes in dACC activity will be measured by the error related negativity (ERN), which is an event related potential generated by the dACC. The ERN is less pronounced in people that score high on impulsivity. It is therefore expect enhanced ERN amplitudes after HD-tDCS over the dACC. In addition, performance on the multisource interference task will be used as measure of dACC activity. It is hypothesize that increased dACC activity will be related to decreased impulsivity in high impulsive individuals as shown by improved inhibitory control on the Go/NoGo task. The results of the study may have implications for patient populations that are characterized by impulsivity.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date January 15, 2020
Est. primary completion date December 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Right-handed - Score > 46 on SUPPS-P Exclusion Criteria: - Score low on trait impulsivity as determined by a score of < 47 on the SUPPS-P short form - History of DSM-5 defined neurological illness, mental illness or traumatic brain injury, - Currently taking any psychoactive medications, - Have metal anywhere in the head, except the mouth. This includes metallic objects such as screws, plates and clips from surgical procedures. - Currently pregnant or lactating, - Being left-handed

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Active High Definition transcranial Direct Current Stimulation (HD-tDCS)
TDCS is a non-invasive neuromodulation technique that modulates membrane potentials by means of small electrical currents. Electrical currents induced by tDCS electrodes produce an electrical field that modulates the excitability of brain areas. In the present HD-tDCS montage, one anodal electrode and four return electrodes are applied. Hereby, the anodal electrode modulates the excitability of the targeted area, whereas the other 4 electrodes return electrical currents that flow away from that area. Direct currents will be transmitted through 5 circular PiStim electrodes of 3.14cm2 (Neuroelectrics, Barcelona, Spain; current density=0.32 mA/cm2) with a current intensity of 1.5 mA. The HD-tDCS session will last for 20 minutes in total, with a 60 sec ramp at the beginning and end of the session. The electrodes will be filled with conductive gel and plugged into an EEG cap, with the anode placed over Fz and the four return electrodes over Fp1, Fp2, F7, and F8 (10-20 system).
Sham High Definition transcranial Direct Current Stimulation (HD-tDCS)
For the sham-condition, the placement of the electrodes was identical to active HD-tDCS stimulation with the anode placed over Fz and the four return electrodes over Fp1, Fp2, F7, and F8 (10-20 system). The direct current, also transmitted through 5 circular PiStim electrodes of 3.14cm2 (Neuroelectrics, Barcelona, Spain; current density=0.32 mA/cm2), was increased in a ramp-like fashion over 60 seconds until it reached 1.5 mA. Directly after ramp-up, the current intensity was gradually switched off over 60 seconds, followed by 20 minutes without active stimulation. Sham procedures for tDCS mimic the transient skin sensation at the beginning of active HD-tDCS, without producing any conditioning effects on the brain. Consequently, participants are reliably blinded for sham tDCS.

Locations

Country Name City State
Australia Monash University, BrainPark Melbourne Victoria

Sponsors (3)

Lead Sponsor Collaborator
Monash University Erasmus University Rotterdam, ZonMw: The Netherlands Organisation for Health Research and Development

Country where clinical trial is conducted

Australia, 

References & Publications (1)

Verveer I, Hill AT, Franken IHA, Yücel M, van Dongen JDM, Segrave R. Modulation of control: Can HD-tDCS targeting the dACC reduce impulsivity? Brain Res. 2021 Apr 1;1756:147282. doi: 10.1016/j.brainres.2021.147282. Epub 2021 Jan 28. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Trait impulsivity as measured by the The Short Version of the Urgency, Premeditation, Perseverance, Sensation Seeking and Positive Urgency Impulsive behaviour scale (SUPPS-P) The SUPPS-P is a widely used robust validated 20-item scale that measures five dimensions of impulsive behavior: negative urgency, premeditation, perseverance, sensation seeking and positive urgency. Participants are asked to indicate how strongly or disagree they agree scale (1 = agree strongly to 4 = disagree strongly) with statements that relate to impulsive tendencies, such as "When I feel bad, I will often do things I later regret in order to make myself feel better now" and "I tend to lose control when I am in a great mood". Higher scores indicate more impulsiveness. For the current study, we used a cut-off score of 47 for high trait impulsivity. This score was determined following analysis of a large database (n = 485) of mental health questionnaires completed by a community sample as part of an ongoing Monash University BrainPark study. Baseline
Other Obsessional Behaviour Questionnaire-44 (OBQ-44) The OBQ-44 is a validated 44-item questionnaire, that measures the degree of obsessional beliefs. Participants are asked to indicate how strongly or disagree they agree scale (1 = disagree very much to 7 = agree very much) with statements about responsibility/threat estimation (e.g. "harmful events will happen unless I am careful"), perfectionism/certainty (e.g. "I must be certain of my decisions"), and importance/control of thoughts (e.g. "having nasty thoughts means I am a terrible person"). A higher score means participants experience stronger obsessional beliefs. Baseline
Other Intolerance of Uncertainty Scale (IUS-12) IUS-12 is a short version of the original 27-item Intolerance of Uncertainty Scale that measures responses to uncertainty, ambiguous situations, and the future. The 12 items are rated on a 5-point Likert scale ranging from 1 (not at all characteristic of me) to 5 (entirely characteristic of me). A higher score indicates more intolerance of uncertainty. Baseline
Other Demographic information Age, Gender, years of education Baseline
Primary Change in error related negativity (ERN) measured by electroencephalography (EEG) after active and sham HD-tDCS To measure changes in electrophysiological measures of error processing after active vs. sham HD-tDCS Baseline, directly after (active vs. sham) HD-tDCS, and 30 min after (active vs. sham) HD-tDCS.
Primary Change in NoGo N2 measured by electroencephalography (EEG) To measure changes in electrophysiological measures of early inhibitory control processes after active vs. sham HD-tDCS Baseline, directly after (active vs. sham) HD-tDCS, and 30 min after (active vs. sham) HD-tDCS.
Primary Change in NoGo P3 measured by electroencephalography (EEG) after active and sham HD-tDCS To measure changes in electrophysiological measures of motor inhibitory control processes after active vs. sham HD-tDCS Baseline, directly after (active vs. sham) HD-tDCS, and 30 min after (active vs. sham) HD-tDCS.
Secondary Change in percentage of correct nogo trials on Go/NoGo task after active vs. sham HD-tDCS To measure the effect of active vs. sham HD-tDCS on accuracy on trials for which responses have to be inhibited. Represents a measure of change in inhibitory control. Baseline, directly after (active vs. sham) HD-tDCS, and 30 min after (active vs. sham) HD-tDCS.
Secondary Change in reaction times on Go trials during Go/NoGo task after active vs. sham HD-tDCS To measure changes in speed of motor responses during Go/NoGo task differences after active vs. sham HD-tDCS Baseline, directly after (active vs. sham) HD-tDCS, and 30 min after (active vs. sham) HD-tDCS.
Secondary Change in reaction times post incorrect trials during Go/NoGo task after active vs. sham HD-tDCS To measure the effect of active vs. sham HD-tDCS on post-error slowing as behavioural measure of error processing. Baseline, directly after (active vs. sham) HD-tDCS, and 30 min after (active vs. sham) HD-tDCS.
Secondary Change in interference effect on multisource interference task (MSIT) after active vs. sham HD-tDCS The interference effect is calculated by subtracting the mean reaction time for congruent trials from the mean reaction time for incongruent trials. A larger interference effect reflects worse performance and is suggested to reflect decreased dACC activity. Baseline, directly after (active vs. sham) HD-tDCS, and 30 min after (active vs. sham) HD-tDCS.
See also
  Status Clinical Trial Phase
Recruiting NCT03898336 - Eat2beNICE Vitamins and Nutrients as Supplementation for Impulsivity, Irritability, and Compulsivity N/A
Completed NCT03484377 - Cortical Dynamics of Inhibitory Control: A Concurrent tDCS-MEG Study N/A
Terminated NCT03527550 - Cognitive Control Training for Urgency in a Naturalistic Clinical Setting N/A
Recruiting NCT03218670 - Your Health in On Click N/A
Not yet recruiting NCT04811807 - Clinical Response of Impulsivity After Brain Stimulation in Parkinson's Disease
Completed NCT02740582 - Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users Phase 2
Not yet recruiting NCT02595164 - Common Decision Making Deficits in Suicidal Behaviors and Eating Disorders N/A
Recruiting NCT04960969 - The Effects of Time-Restricted Eating Model N/A
Not yet recruiting NCT03498937 - Effects of tDCS on Impulsiveness Among People Suffering From Borderline Personality Disorder N/A
Completed NCT03200873 - Effects of rTMS on Impulsivity and Empathy N/A
Terminated NCT03838484 - Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia N/A
Completed NCT05031559 - Episodic Future Thinking and Compassion N/A
Completed NCT01158950 - A Study of Neural Circuit Responses to Catechol-O-methyl Transferase (COMT) Inhibitors N/A
Recruiting NCT05875181 - Examining the Impact of Transcranial Focused Ultrasound (tFUS) on Reward Neural Circuitry N/A
Not yet recruiting NCT05894980 - How to Reduce Suicidal Thoughts and Impulsivity in Depression N/A
Not yet recruiting NCT03190681 - Motivation and Methylphenidate Early Phase 1
Completed NCT01805401 - tDCS Applied to the OFC: Effects on Decision-Making and Impulse Control N/A
Completed NCT03006653 - Understanding Daily Fluctuations in Self-Regulation N/A
Active, not recruiting NCT04785677 - Researching Resiliency in Stressful Experiences (RISE) Program for Men Leaving Incarceration N/A
Active, not recruiting NCT04848532 - Problematic Decision-Making and Adolescent Weight Loss N/A